Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.idh.2020.05.002 http://scihub22266oqcxt.onion/10.1016/j.idh.2020.05.002 32473952!7237903!32473952     free     free     free       Infect+Dis+Health 2020 ; 25 (3): 210-215 Nephropedia Template TP {{tp|p=32473952|t=2020. SARS-CoV-2: The viral shedding vs infectivity dilemma |pdf=|usr=}}{{32473952}} gab.com Text SARS-CoV-2: The viral shedding vs infectivity dilemma JO: Infect Dis Health http://www.kidney.de/pget.php?&tw=1&pmid=32473952 #FOAvip Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over four million people worldwide. There are multiple reports of prolonged viral shedding in people infected with SARS-CoV-2 but the presence of viral RNA on a test does not necessarily correlate with infectivity. The duration of quarantine required after clinical recovery to definitively prevent transmission is therefore uncertain. In addition, asymptomatic and presymptomatic transmission may occur, and infectivity may be highest early after onset of symptoms, meaning that contact tracing, isolation of exposed individuals and social distancing are essential public health measures to prevent further spread. This review aimed to summarise the evidence around viral shedding vs infectivity of SARS-CoV-2. Twit Text FOAVip SARS-CoV-2: The viral shedding vs infectivity dilemma ????Infect Dis Health http://www.kidney.de/pget.php?&tw=1&pmid=32473952 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32473952 #FOAvip English Wikipedia <ref>{{Cite pmid|32473952}}</ref> SARS-CoV-2: The viral shedding vs infectivity dilemma #MMPMID32473952 Widders A; Broom A; Broom J Infect Dis Health 2020[Aug]; 25 (3): 210-215 PMID32473952show ga Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over four million people worldwide. There are multiple reports of prolonged viral shedding in people infected with SARS-CoV-2 but the presence of viral RNA on a test does not necessarily correlate with infectivity. The duration of quarantine required after clinical recovery to definitively prevent transmission is therefore uncertain. In addition, asymptomatic and presymptomatic transmission may occur, and infectivity may be highest early after onset of symptoms, meaning that contact tracing, isolation of exposed individuals and social distancing are essential public health measures to prevent further spread. This review aimed to summarise the evidence around viral shedding vs infectivity of SARS-CoV-2. |*Virus Shedding[MESH] |Asymptomatic Infections[MESH] |Betacoronavirus/*pathogenicity[MESH] |COVID-19[MESH] |Coronavirus Infections/diagnosis/*etiology/transmission/virology[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/diagnosis/*etiology/transmission/virology[MESH] |Public Health[MESH] |SARS-CoV-2[MESH]SARS-CoV-2: The viral shedding vs infectivity dilemma (epmc).pdf DeepDyve Pubget Overpricing